Elsevier

Atherosclerosis

Volume 128, Issue 1, 3 January 1997, Pages 97-105
Atherosclerosis

The influence of antioxidant nutrients on platelet function in healthy volunteers

https://doi.org/10.1016/S0021-9150(96)05974-6Get rights and content

Abstract

There is mounting evidence that antioxidants may help to prevent coronary heart disease and modulate some thrombotic events such as platelet adhesion. However, the effects of antioxidant supplementation on platelet function in vivo are controversial. A double-blind, randomised, placebo-controlled study was performed on 40 healthy volunteers (20–50 years) supplemented daily with vitamin E (300 mg), vitamin C (250 mg) or β-carotene (15 mg) for 8 weeks. Platelet function was assessed by platelet aggregation induced by ADP, arachidonic acid or collagen, platelet responsiveness to the inhibitor PGE1, β-thromboglobulin release and ATP secretion. Supplementation with vitamin E resulted in a significant increase in platelet α-tocopherol level (+68%) reflecting closely the increase in plasma α-tocopherol level (+69%). Platelet function was significantly decreased by vitamin E as revealed by the decreased platelet aggregation in response to ADP and arachidonic acid, the increased sensitivity to inhibition by PGE1, the decreased plasma β-thromboglobulin concentration and the decreased ATP secretion. Supplementation with vitamin C did not affect platelet function significantly although a trend towards a decreased platelet aggregability and an increased sensitivity to the inhibitor PGE1 were observed. No significant changes in platelet function occurred after supplementation with β-carotene. In conclusion, supplementation of healthy volunteers with vitamin E decreased platelet function whereas supplementation with vitamin C or β-carotene had no significant effects.

Introduction

Blood platelets are important contributors to thrombosis and possibly to the development of atherosclerosis 1, 2. Once the endothelium is injured, the earliest event is the adhesion of circulating platelets to the subendothelium followed by platelet aggregation and secretion of the granule contents. During platelet activation, arachidonic acid (AA) is released from membrane phospholipids and oxygenated into different biologically active metabolites including thromboxane A2 (TXA2), a potent aggregating agent [3]. Other vasoactive molecules are released such as 5-hydroxytryptamine (serotonin), noradrenaline, ADP and ATP from the dense granules, whereas β-thromboglobulin and platelet-derived growth factor (PDGF), a mitogenic factor, are released from the α-granules. Free radicals have been involved in processes regulating platelet function 4, 5. In particular, low concentrations of lipid hydroperoxides stimulate cyclooxygenase [6]thereby leading to an increased formation of the pro-aggregatory metabolite, TXA2. On the contrary, lipid peroxides inhibit prostacyclin synthase [7], an enzyme mainly present in endothelial cells which catalyses the formation of prostacyclin (PGI2), an inhibitor of platelet aggregation [8].

The outcome of the Physicians' Health Study was that 12 years of supplementation with β-carotene produced neither benefit nor harm in terms of cardiovascular disease [9]. There is increasing evidence for the role of dietary antioxidant nutrients (namely vitamin E and vitamin C) in the prevention of initiation and development of atherosclerosis (reviewed in 10, 11, 12). However, their mechanisms of action are still under current investigation. Besides the protection of low-density lipoprotein from oxidation (reviewed in 13, 14), antioxidants act at the cellular level and may modulate some thrombotic events such as platelet aggregation. In particular, antioxidants, via their ability to reduce the formation of lipid peroxides, may decrease levels of TXA2 relative to PGI2 and thus platelet hyperactivation. It is recognised that antioxidants (namely vitamin E and vitamin C) decrease platelet aggregation in vitro 15, 16. Although supplementation of patients with vitamin E decreases platelet aggregation 17, 18, the effect of antioxidant nutrient supplementation of normal healthy subjects on platelet function is controversial.

The aim of the present study was to determine whether supplementation of healthy volunteers with either vitamin E, vitamin C or β-carotene for 56 days influence platelet function assessed by platelet aggregation induced by varying concentrations of specific agonists (ADP, collagen, arachidonic acid), platelet responsiveness to the inhibitor PGE1, β-thromboglobulin release and ATP secretion. In particular, the relationship between the levels of antioxidant nutrients and the tendency for platelets to aggregate was investigated.

Section snippets

Subjects

40 healthy volunteers (24 men, 16 women) aged between 20 and 50 years (mean±S.D., 31.2±8.8) participated in the study. There were no significant differences between the four groups with respect to age, body mass index (mean±S.D., 23.6±3.7 kg/m2) and lipid profiles. Exclusion criteria included smoking, heavy drinking, consumption of antioxidant and mineral supplements, oral contraceptives, taking aspirin or specified drugs interfering with platelet functions for two weeks before the study and

Results

As previously reported [19], supplementation with 300 mg vitamin E resulted in a significant increase of plasma α-tocopherol (+69%, 20.6±1.7→34.9±3.3 μM, P<0.001) or α-tocopherol/cholesterol ratio (4.25±0.43→7.60±0.89 μM, P=0.001) compared with placebo. Vitamin C supplementation (250 mg) led to a 26% increase of plasma mean ascorbic acid level (65.2±6.3→81.8±4.2 μM, P=0.001) whereas ingestion of 15 mg β-carotene increased plasma β-carotene by 253% (0.84±0.12→3.07±0.35 μM, P<0.001). There were

Discussion

Although it is well established that vitamin E inhibits platelet aggregation in vitro 15, 25, 26, 27, 28, platelet adhesion in vivo [29]and also the platelet release reaction [30], reports on the effect of vitamin E supplementation on normal healthy subjects on platelet function in vivo, have been controversial and at best variable. The results of this double-blind, randomised, placebo-controlled trial with detailed examination of platelet responses to agonists and an antagonist provide

Acknowledgements

The authors thank the Ministry of Agriculture, Fisheries and Food for financial support for this project. The authors gratefully acknowledge Roche Nicholas, Geneva for providing the supplements and Roche Nicholas, Welwyn for monitoring the trial. We are grateful to the participants for their cooperation and to Dr Vimala Gopinathan and Ms Sally Brett for clinical assistance.

References (47)

  • Elwood PC, Renaud S, Sharp DS, Bewick AD, O'Brien JR, Yarnell JWG. Ischaemic heart disease and platelet aggregation;...
  • Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature...
  • Smith JB. The prostanoids in hemostasis and thrombosis. Am J Pathol...
  • Salvemini D, De Nucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. Br J...
  • Iuliano L, Pederson JZ, Pratico D, Rotilio G, Violi F. Role of hydroxyl radicals in the activation of human platelets....
  • Kulmacz RJ, Lands WEM. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin...
  • Moncada S, Gryglewski R, Bunting S, Vane JR. A lipid peroxide inhibits the enzyme in blood vessel microsomes that...
  • Bunting SR, Gryglewski R, Moncada AS, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance...
  • Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta-carotene on the...
  • Rice-Evans C, Diplock AT. Current status of antioxidant therapy. Free Rad Biol Med...
  • Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Luedin E. Increased risk of cardiovascular disease at suboptimal...
  • Diplock AT. Antioxidants and disease prevention. Mol Aspects Med...
  • Rice-Evans C, Bruckdorfer KR. Free radicals, lipoproteins and cardiovascular dysfunction. Mol Aspects Med...
  • Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet...
  • Steiner M. Inhibition of platelet aggregation by alpha-tocopherol. In: deDuve C, Hayaishi O. (eds). Tocopherol, Oxygen...
  • Cordova C, Musca A, Violi F, Perrone A, Alessandri C. Influence of ascorbic acid on platelet aggregation in vitro and...
  • Colette C, Pares-Herbute N, Monnier LH, Cartry E. Platelet function in type I diabetes: effects of supplementation with...
  • De Lorgeril M, Boissonnat P, Salen P et al. The beneficial effect of dietary antioxidant supplementation on platelet...
  • Calzada C, Bizzotto M, Paganga G, Miller N, Bruckdorfer KR, Diplock AT, Rice-Evans CA. Levels of antioxidant nutrients...
  • Lagarde M, Bryon PA, Guichardant M, Dechavanne M. A simple and efficient method for platelet isolation from their...
  • Rice-Evans CA, Diplock AT, Symons MCR. In: Techniques in Free Radical Research. Amsterdam: Elsevier,...
  • Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature...
  • Schafer AI, Cooper B, O'Hara D, Handin RI. Identification of platelet receptors for prostaglandins I2 and D2. J Biol...
  • Cited by (104)

    • Resveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine phosphatase-2

      2015, Free Radical Biology and Medicine
      Citation Excerpt :

      Thus, NOX has been suggested as a novel target for anti-platelet agent development [22]. Platelet stimulation may also be inhibited by a number of dietary components including antioxidants [23]. Resveratrol (3,4′,5-trihydroxystilbene), a polyphenolic compound found in mulberries, grapes and red wine [24], has been found to strongly inhibit the aggregation of platelets stimulated with collagen [25,26].

    • Vitamin E and Immunity

      2011, Vitamins and Hormones
      Citation Excerpt :

      This theory, proposed by Morel et al. (1984), Steinberg and Witztum (1990), and Mitchinson (1994), is now generally accepted and provides a strong biological plausibility for the role of vitamin E in preventing CVD. Vitamin E supplementation also leads to a decrease in platelet aggregability; neither vitamin C nor β-carotene has this effect (Calzada et al., 1997; Mower and Steiner, 1982). Clinical trials have also shown certain benefits of supplemental intake of vitamin E. Hodis et al. (1995) reported a significantly retarded progression in coronary lesions among men who had previously undergone coronary artery bypass graft surgery and were supplemented with vitamin E. Through careful selection and incorporation of ingredients containing high amounts of vitamin E into daily meals, one can increase dietary intake of vitamin E to 60 IU/day; however, an intake of 200 IU/day is attainable only by supplementation (Meydani, 2000).

    • Vitamin E: Inflammation and Atherosclerosis

      2007, Vitamins and Hormones
      Citation Excerpt :

      The understanding of various regulatory, nonoxidative response to α‐T by crucial cells involved in the pathogenesis of atherosclerosis is very important. As discussed above, such responses include inhibition of SMC proliferation, preservation of endothelial function, inhibition of MO‐EC adhesion, inhibition of monocyte ROS and cytokine release, and inhibition of platelet adhesion and aggregation (Calzada et al., 1997; Kaul et al., 2001; Singh and Jialal, 2004; Singh et al., 2005; Steiner, 1983). These cellular responses to α‐T are associated with transcriptional and posttranscriptional events.

    View all citing articles on Scopus
    1

    Present address: INSERM U 352 (affiliated to CNRS), Biochimie et Pharmacologie, INSA-Lyon, Villeurbanne, France.

    View full text